Treatment of Malaria vivax and falciparum with Ultraviolet :紫外线治疗间日疟原虫和恶性疟原虫疟疾.doc

Treatment of Malaria vivax and falciparum with Ultraviolet :紫外线治疗间日疟原虫和恶性疟原虫疟疾.doc

  1. 1、本文档共9页,可阅读全部内容。
  2. 2、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Treatment of Malaria vivax and falciparum with Ultraviolet :紫外线治疗间日疟原虫和恶性疟原虫疟疾

Treatment of Malaria vivax and falciparum with ultraviolet C light via sublingual application: a clinical report of 3 cases José Aranda, MD and Martha Villar, MD Complementary Medicine Treatment center, Department of medicine of Hospital III (Centro de Atención de Medicina Complementaria, Departamento de Medicina del Hospital III) Loreto Assistance Network, Health Social Security- EsSALUD, Peru. ( Red Asistencial Loreto, Seguro Social de Salud- EsSalud, Perú) SUMMARY: Malaria is a public health problem for Peru, where malaria increased fourfold from 1992 to 1997, and chloroquine and pyrimethamine-sulfadoxine drug-resistant P. falciparum strains have emerged. In light of these factors, a variation on an old non-pharmacologic treatment was applied in 3 cases. This report focuses on the clinical presentation and treatment with ultraviolet C light of 3 malaria cases. Two patients with malaria vivax and one with falciparum decided not to receive the pharmacological treatment but instead, by their own choice, opted to receive the ultraviolet C light (at a wavelength of 254 nm) sublingually. The disappearance of the symptoms, negative thick drop and the absence of parasites in the patients that received ultraviolet C light suggests further studies with application of ultraviolet C sublingually is warranted as a promising therapy for malaria treatment. KEY WORDS: Malaria vivax, Malaria falciparum, ultraviolet light C, therapeutic use. INTRODUCTION: According to the World Health Organization’s 2008 report, an estimated 221,808 cases of Malaria in Peru resulted in an estimated 128 deaths from the disease in 2006. The pharmacological treatment plan is unique and free throughout Peru, is guaranteed by the state in all of the health clinics and establishments, and has been evaluated according to efficiency and efficacy criteria. In uncomplicated malaria from Plasmodium vivax, the treatment lasts 7 days and efficacy control tests takes place on the 14th day. In uncomplicated ma

文档评论(0)

小教资源库 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档